001     165278
005     20230915090615.0
024 7 _ |a 10.1016/j.eclinm.2022.101651
|2 doi
024 7 _ |a pmid:36133318
|2 pmid
024 7 _ |a pmc:PMC9482331
|2 pmc
024 7 _ |a altmetric:136116940
|2 altmetric
037 _ _ |a DZNE-2022-01571
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Hartung, Tim J
|b 0
245 _ _ |a Fatigue and cognitive impairment after COVID-19: A prospective multicentre study.
260 _ _ |a Amsterdam
|c 2022
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1665568479_29940
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a CC BY: https://creativecommons.org/licenses/by/4.0/
520 _ _ |a Reliable estimates of frequency, severity and associated factors of both fatigue and cognitive impairment after COVID-19 are needed. Also, it is not clear whether the two are distinct sequelae of COVID-19 or part of the same syndrome.'In this prospective multicentre study, frequency of post-COVID fatigue and cognitive impairment were assessed in n = 969 patients (535 [55%] female) ≥6 months after SARS-CoV-2 infection with the FACIT-Fatigue scale (cut-off ≤30) and Montreal Cognitive Assessment (≤25 mild, ≤17 moderate impairment) between November 15, 2020 and September 29, 2021 at University Medical Center Schleswig-Holstein, Campus Kiel and University Hospital Würzburg in Germany. 969 matched non-COVID controls were drawn from a pre-pandemic, randomised, Germany-wide population survey which also included the FACIT-Fatigue scale. Associated sociodemographic, comorbid, clinical, psychosocial factors and laboratory markers were identified with univariate and multivariable linear regression models.On average 9 months after infection, 19% of patients had clinically relevant fatigue, compared to 8% of matched non-COVID controls (p < 0.001). Factors associated with fatigue were female gender, younger age, history of depression and the number of acute COVID symptoms. Among acute COVID symptoms, altered consciousness, dizziness and myalgia were most strongly associated with long-term fatigue. Moreover, 26% of patients had mild and 1% had moderate cognitive impairment. Factors associated with cognitive impairment were older age, male gender, shorter education and a history of neuropsychiatric disease. There was no significant correlation between fatigue and cognitive impairment and only 5% of patients suffered from both conditions.Fatigue and cognitive impairment are two common, but distinct sequelae of COVID-19 with potentially separate pathophysiological pathways.German Federal Ministry of Education and Research (BMBF).
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a CI, confidence interval
|2 Other
650 _ 7 |a COVID-19
|2 Other
650 _ 7 |a COVID-19, Coronavirus Disease 2019
|2 Other
650 _ 7 |a CRP, C-reactive protein
|2 Other
650 _ 7 |a CSF, cerebrospinal fluid
|2 Other
650 _ 7 |a Cognitive dysfunction
|2 Other
650 _ 7 |a Fatigue
|2 Other
650 _ 7 |a GAD-7, 7-item anxiety screening questionnaire
|2 Other
650 _ 7 |a MoCA, Montreal Cognitive Assessment
|2 Other
650 _ 7 |a NAPKON, National Pandemic Cohort Network
|2 Other
650 _ 7 |a PCR, polymerase chain reaction
|2 Other
650 _ 7 |a PHQ-8, 8-item depression module of the Patient Health Questionnaire
|2 Other
650 _ 7 |a PSQI, Pittsburgh Sleep Quality Index
|2 Other
650 _ 7 |a Post-acute COVID-19 syndrome
|2 Other
650 _ 7 |a SARS-CoV-2
|2 Other
650 _ 7 |a SARS-CoV-2, Severe Acute Respiratory Distress Syndrome caused by Corona Virus 2
|2 Other
650 _ 7 |a VIF, variance inflation factor
|2 Other
700 1 _ |a Neumann, Christian
|b 1
700 1 _ |a Bahmer, Thomas
|b 2
700 1 _ |a Chaplinskaya-Sobol, Irina
|b 3
700 1 _ |a Endres, Matthias
|0 P:(DE-2719)2811033
|b 4
|u dzne
700 1 _ |a Geritz, Johanna
|b 5
700 1 _ |a Haeusler, Karl Georg
|b 6
700 1 _ |a Heuschmann, Peter U
|b 7
700 1 _ |a Hildesheim, Hanna
|b 8
700 1 _ |a Hinz, Andreas
|b 9
700 1 _ |a Hopff, Sina
|b 10
700 1 _ |a Horn, Anna
|b 11
700 1 _ |a Krawczak, Michael
|b 12
700 1 _ |a Krist, Lilian
|b 13
700 1 _ |a Kudelka, Jennifer
|b 14
700 1 _ |a Lieb, Wolfgang
|b 15
700 1 _ |a Maetzler, Corina
|0 P:(DE-2719)2501881
|b 16
|u dzne
700 1 _ |a Mehnert-Theuerkauf, Anja
|b 17
700 1 _ |a Montellano, Felipe A
|b 18
700 1 _ |a Morbach, Caroline
|b 19
700 1 _ |a Schmidt, Sein
|b 20
700 1 _ |a Schreiber, Stefan
|0 P:(DE-2719)2812631
|b 21
|u dzne
700 1 _ |a Steigerwald, Flo
|b 22
700 1 _ |a Störk, Stefan
|b 23
700 1 _ |a Maetzler, Walter
|0 P:(DE-2719)2810915
|b 24
|u dzne
700 1 _ |a Finke, Carsten
|0 P:(DE-2719)9001141
|b 25
|u dzne
773 _ _ |a 10.1016/j.eclinm.2022.101651
|g Vol. 53, p. 101651 -
|0 PERI:(DE-600)2946413-4
|p 101651
|t EClinicalMedicine
|v 53
|y 2022
|x 2589-5370
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/165278/files/DZNE-2022-01571.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/165278/files/DZNE-2022-01571.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:165278
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2811033
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 16
|6 P:(DE-2719)2501881
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 21
|6 P:(DE-2719)2812631
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 24
|6 P:(DE-2719)2810915
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 25
|6 P:(DE-2719)9001141
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2022
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2020-08-31
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2020-08-31
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ECLINICALMEDICINE : 2021
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-01-26T13:10:03Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-01-26T13:10:03Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-01-26T13:10:03Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-10
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b ECLINICALMEDICINE : 2021
|d 2022-11-10
920 1 _ |0 I:(DE-2719)1811005
|k AG Endres
|l Coordinator of Clinical Research
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1811005
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21